Retinoids during the in vitro transition from bovine morula to blastocyst

Genética y Reproducción, SERIDA, Gijón, Asturias, Spain.
Human Reproduction (Impact Factor: 4.57). 09/2006; 21(8):2149-57. DOI: 10.1093/humrep/del099
Source: PubMed


The conversion of retinol (ROH) to retinoic acid (RA) is crucial during development but has been not studied during blastocyst formation.
In vitro-produced bovine morulae were treated for 24 h with citral (which inhibits the synthesis of RA from ROH), citral + all trans retinoic acid (ATRA), ATRA or no additives. Citral interfered with blastocyst development, whereas exogenous RA had no effect. RA, however, reversed the effect of citral on development and stimulated cell proliferation. Neither citral nor RA changed the apoptotic index, but RA triggered an increase in the apoptotic frequency of the inner cell mass. Citral and RA reduced the necrotic index. Na/K-ATPase alpha1-subunit mRNA concentrations (analysed by real-time PCR) increased after hatching and showed dependence on retinoid activity, but no evidence was found of any retinoid effect on p53 expression. Nevertheless, the p53 mRNA concentration increased in response to proliferation in hatched blastocysts.
The preimplantation bovine embryo metabolizes endogenous ROH to RA, which participates in important cell processes. The true extent of the influence of RA is unknown, although the modulation of retinoid metabolism seems to be a means of increasing cell proliferation. This knowledge might be used to improve embryo quality and the efficiency of stem cell derivation.

Download full-text


Available from: Felix Goyache, Jul 30, 2014
  • Source
    • "After the TUNEL reaction, the nuclei were stained for 10 minutes with 10 mg/mL bisbenzimide in PBS-PVA. The blastocysts were then washed in PBS with 0.1 mg/ mL of PVA, mounted on a glass slide with droplets of Vectashield 4 0 ,6-diamidino-2-phenylindole, flattened with a coverslip, and examined under an Olympus IX50 fluorescence microscope [33] "
    [Show abstract] [Hide abstract]
    ABSTRACT: Vitrification is an alternative to slow-rate freezing for cryopreserving bovine embryos. However, this technology requires simplification if it is to be used under field conditions. The main objective of this work was to develop a new system for the direct transfer of vitrified embryos to be used under farm conditions. For this, three objectives were set: (1) to compare the effect of vitrification, using the cryologic vitrification method (CVM), and slow-rate freezing on bovine embryo development and quality; (2) to develop a one-step warming procedure for bovine in vitro-produced (IVP) vitrified (by CVM) embryos; and (3) to assess the effects on embryo survival of a new method for the direct transfer of vitrified IVP bovine blastocysts. In vitro-produced blastocysts were initially either vitrified by CVM or subjected to slow freezing to compare embryo survival and quality (experiment 1). No differences were detected between these cryopreservation techniques in terms of the survival and quality variables at 24 hours or in terms of the proteins expressed. However, at 48 hours the vitrified embryos showed higher hatching rates, greater total cell numbers, and lower apoptotic indices (P < 0.05). In experiment 2, CVM-vitrified IVP blastocysts were warmed by the conventional two-step or one-step warming procedure by incubating them at 41 °C in 0.25 M sucrose for 10 minutes, 0.15 M sucrose for 10 minutes, or 0.25 M sucrose for 5 minutes. In addition, embryo transfer (ET) was performed using vitrified embryos warmed by the one-step procedure in 0.25 M sucrose solution for 5 minutes. As a control group, IVP fresh embryos were transferred to recipient females. No differences were observed in embryo survival or total cell number between any of the warming procedures. Moreover, no significant differences for pregnancy at 60 days were found between the ET groups. In experiment 3, expanded IVP blastocysts were then either vitrified using a conventional or a modified fiber plug designed to allow direct ET after in-straw cryoprotectant (CP) dilution. They were warmed using the one-step process (0.25 M sucrose, 5 minutes) in a 0.25 mL French straw. Embryo recovery associated with the modified fibreplug system was less reliable than with the conventional system. However, no differences were seen between the systems in terms of in vitro embryo survival among those finally recovered. Finally, IVP blastocysts were vitrified using conventional fibreplugs to maintain a high embryo recovery rate, and then warmed using the one-step warming in-straw CP dilution procedure, but using an adapter with a wider opening coupled to the French straw and a heated metal chamber to protect and keep the straw at 41 °C (experiment 4). No differences were seen in embryo survival rates between the two groups. The CVM combined with this new one-step warming in-straw CP dilution procedure could be used for direct ET under field conditions. Copyright © 2015 Elsevier Inc. All rights reserved.
    Full-text · Article · Nov 2014 · Theriogenology
  • Source
    • "Positive effects of activin A on embryo development were shown when the protein was added at the earliest stages of bovine [10] and murine [11] embryo culture, while no effects on bovine blastocysts rates were reported by Park and co-workers (2008). Experiments with in vitro produced (IVP) embryos may include analysis for development and quality [12]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: The aim of this study was to investigate the effects of activin A on development, differential cell counts and apoptosis/necrosis rates of bovine embryos produced in vitro. Presumptive zygotes were cultured up to Day 8 in synthetic oviduct fluid containing aminoacids, citrate, myo-inositol and BSA. In Experiment 1, activin (10 ng mL(-1)) was added: 1/from Day 1 to Day 3; 2/from Day 1 to Day 8; 3/from Day 3 to Day 8; or 4/absent (control). In Experiment 2, 10 ng mL(-1) activin were added either before (Day 3 to Day 5) or after (Day 5 to Day 8) the early morula stage. In Experiment 1, activin during the first 72 h of culture reduced Day 3 cleavage, 5-8 cell rates and blastocyst development, while hatching rates increased. No changes were observed within differential cell counts. In experiment 2, activin improved blastocyst development after, and had no effect before, the Day 5 morula stage. However, trophectoderm (TE) cell numbers decreased with activin both before and after the Day 5 morula stage, suggesting that activin inhibits TE differentiation. The presence of activin during the whole culture had no effect on TUNEL positive cells, but when added at shorter periods activin increased apoptotic rates. Effects of activin during in vitro bovine embryo development, depends on timing of its addition to the culture medium.
    Full-text · Article · Oct 2010 · Theriogenology
  • Source
    • "The reported effects of retinoic acid on embryo development are inconclusive: some show it is beneficial to embryo development [44, 45], others show it is detrimental [46, 47]. A recent report shows LG100268 (a synthetic RXR ligand) reduces trophectoderm cell proliferation in a concentration-dependent manner, but enhances the development of bovine blastocysts at 0.1 μM [48]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Peroxisome proliferator-activated receptor delta (PPARdelta, also known as PPARbeta) has ubiquitous distribution and extensive biological functions. The reproductive function of PPARdelta was first revealed in the uterus at the implantation site. Since then, PPARdelta and its ligand have been discovered in all reproductive tissues, including the gametes and the preimplantation embryos. PPARdelta in preimplantation embryos is normally activated by oviduct-derived PPARdelta ligand. PPARdelta activation is associated with an increase in embryonic cell proliferation and a decrease in programmed cell death (apoptosis). On the other hand, the role of PPARdelta and its ligand in gamete formation and function is less well understood. This review will summarize the reproductive functions of PPARdelta and project its potential applications in assisted reproductive technology.
    Full-text · Article · Feb 2008 · PPAR Research
Show more